Skip to main content

Elan Pharma Licenses Ariadne's Software

NEW YORK (GenomeWeb News) – Elan Pharmaceuticals has licensed Ariadne Genomics’ Pathway Studio software to support its therapeutics research for neurological and autoimmune diseases, Ariadne said Thursday.
 
The Pathway Studio includes the ResNet database of functional relationships, which is used to interpret microarray data and for researching signaling networks, and MedScan, which is a tool that extracts pathway related information from research literature.
 
Financial terms of the agreement were not released.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.